Subcutaneous depo-medroxyprogesterone acetate [PDF]
Journal of Family Planning and Reproductive Health Care, 2013 Since 2004, a micronised formulation of depo-medroxyprogesterone acetate (DMPA) that is delivered as a subcutaneous injection has been available. It is currently in clinical use in the USA and in nine countries throughout Europe.1 As of March 2013 this product is being marketed in the UK as Sayana® Press (Pfizer, UK).
openaire +2 more sources
A pilot investigation of load-carrying on the head and bone mineral density in premenopausal, black African women [PDF]
, 2010 Although the influence of weight bearing activity on bone mass has been widely investigated in white women, few studies have been conducted in black, African populations.
Carroll, Sean +7 more
core +3 more sources
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate. [PDF]
, 2020 ObjectiveTo evaluate serum estradiol (E2) concentrations during use of 90-day contraceptive vaginal rings releasing E2 75, 100, or 200 mcg/day and segesterone acetate (SA) 200 mcg/day to identify a dose that avoids hypoestrogenism.Study ...
Archer, David F +12 more
core +1 more source
Pancreatic cancer cachexia: a review of mechanisms and therapeutics. [PDF]
, 2014 Over the last decade, we have gained new insight into the pathophysiology of cachexia associated with pancreatic cancer. Unfortunately, its treatment is complex and remains a challenge.
Andrew Eugene Hendifar +8 more
core +2 more sources
Effect of Staff Training and Cost Support on Provision of Long-Acting Reversible Contraception in Community Health Centers [PDF]
, 2019 Objective To compare the proportion of women receiving same-day long-acting reversible contraception (LARC) between two different models of contraceptive provision adapted from the Contraceptive CHOICE Project. Study Design We used a controlled time-
Buckel, Christina +4 more
core +1 more source
Middle East Fertility Society Journal, 2016 Objective: This study was aimed to investigate the effect of combined vitamin C and E on serum leptin, visceral fat mass, and visceral fat oxidative stress in rats treated by depot-medroxyprogesterone acetate (DMPA).
Endang Sri Wahyuni +2 more
doaj +1 more source
Potential Deleterious Effects Following the First Dose of Medroxyprogesterone Acetate as a Contraceptive in Cats [PDF]
Journal of Applied Veterinary Sciences, 2023 The aim of the present work was to investigate the deleterious effects of the first dose of medroxyprogesterone acetate (MPA) on the female genital system of cats.
Ahmed Abdelgalil
doaj +1 more source
Medroxyprogesterone acetate exacerbates glutamate excitotoxicity
Gynecological Endocrinology, 2006 We previously demonstrated that progesterone functions as a neuroprotective agent whereas medroxyprogesterone acetate (MPA; Provera) does not. Moreover, MPA antagonized the neuroprotective and neurotrophic outcomes induced by 17beta-estradiol (E2). Towards developing effective hormone therapies for protection against neurodegeneration, we sought to ...
Jon, Nilsen +2 more
openaire +2 more sources
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial [PDF]
Contraception, 2016 To describe medroxyprogesterone acetate (MPA) levels among Kenyan depot medroxyprogesterone acetate (DMPA) users in the FEM-PrEP HIV prevention trial, and to compare MPA levels between ARV for HIV prevention (treatment) and placebo groups.We measured MPA in previously collected plasma samples from 63 Kenyan trial participants who used DMPA for one or ...
Nanda, Kavita +7 more
openaire +2 more sources
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia [PDF]
, 2009 Background: The majority of acute myeloid leukaemia (AML) patients are over sixty years of age. With current treatment regimens, survival rates amongst these, and also those younger patients who relapse, remain dismal and novel therapies are urgently ...
Alessia Lodi +15 more
core +5 more sources